OmniAb, Inc.OABIEarnings & Financial Report

Nasdaq · Industrials · Services-Commercial Physical & Biological Research

OmniAb, Inc. is a global biotechnology firm specializing in proprietary transgenic animal platforms and antibody discovery solutions. It partners with pharma and biotech clients to accelerate fully human therapeutic antibody development for oncology, autoimmune diseases and high-need medical areas across key global markets.